BD Neopak™ Glass Prefillable Syringe (PFS) platform and Integrated Drug Delivery
Committed to drug delivery excellence
- Overview
- Products & Accessories
- Resources
The BD Neopak™ Glass Prefillable Syringe platform with tailorable medication delivery solution can help support the development of your biologic drug.
Getting your drug to market with a solution focused on patient safety and usability
Our diverse portfolio features devices and systems that can deliver biologics across a wide range of volumes and viscosities, helping to treat patients with chronic conditions.
Various configurations
- Available in 1ml and 2.25 ml configurations
- Designed to enhance patient experience when administering high viscosity/high volume drugs 2,3
- Shorter 8mm needle
- Thinner wall cannula technology
Positive patient acceptance
- May help reduce the risk of intramuscular injection2
- Decreased injection force and/or time at a fixed solution viscosity3
- Reduced needle related anxiety2
- Positive impact on patient acceptance2
Enhanced particle reduction with immobilized silicone coating
- Designed to stabilise the silicone lubricant layer without introducing new chemistry4,5*
- Enhanced particle reduction with immobilised silicone coating
Compatibility with sensitive biopharmaceuticals
- Minimizing sub-visible particle generation to help meet compliance standards for particulates4,5,6
- Stabilised silicone lubricant layer and mechanical properties to aid in full drug
- delivery4,5,6,7
- Maintained gliding and activation performance over time, as compared to
- conventional silicone5
*XSi does not introduce new chemical substances or molecule entity and only modifies the distribution of chemical functions which already exists in PDMS (Polydimethylsiloxane) silicone
** USP 788 standard
- World Preview 2018, Outlook to 2024. Evaluate Pharma, 2018
- User experience for manual injection of 2 mL viscous solutions is enhanced by a new prefillable syringe with a stacked 8 mm ultra-thin wall needle, Expert Opinion on Drug Delivery, Pager 2020
- Injection time and ejection force calculation, BD internal study, 2020
- Depazet al. Cross-Linked Silicone Coating: A Novel Prefilled Syringe Technology That Reduces Subvisible Particles and Maintains Compatibility with Biologics. JOURNAL OF PHARMACEUTICAL SCIENCES 103:1384–1393, 2014
- BD Neopak™ XSi™ 1mlL-Competitive Benchmark [Internal Study]. Pont-de-Claix, FR: Becton Dickinson and Company; 2020
- BD Neopak™ XSi™ 2.25ml 27G STW ½’’ - Empty AGF. [internal Study].Pont-de-Claix, FR: Becton Dickinson and Company. 2019
- BD Neopak™ XSi™ 2.25ml 27G STW ½’’ - injection time. [internal Study]. Pont-de-Claix, FR: Becton Dickinson and Company. 2019
Our collection of literature on industries and on our offerings gives you information you can use to continue striving for excellence.
